🚀 Your Premium Trade Alerts (Dec 3)

Open Email...Your Options Trades Ideas (Around Earnings Announcements) Inside

	Unsubscribe
📢 Investor Alert: $2 Trillion Cybersecurity Boom—Don't Miss Out! (ad)*
Dear Fellow Trader, I hope this trading day has been good to you! I am sending you trade ideas for tomorrow. So you can have enough time to take action on our trades ideas. [Limited Chance] ⏳ Insights into the Biotech Investment Strategies of Billionaires! (ad)* After creating the world's first billionaire, biotech companies are responsible for some of the biggest breakthroughs for human health and investor's pockets on the market!... Now a tiny company is set to go public and is trying to disrupt a $96 billion industry. 🎯 Take a look before it goes public. Options Trade Ideas (Volatility Rush Strategy) The basic option trade idea is to buy an at-the-money straddle while the options premium is cheap. In assessing this trade, you need to do your homework to ensure you are not paying too much for the straddle. As the earnings date approaches, the implied volatility (IV) should increase, resulting in greater price movement. However, be aware that you should close your position before the announcement comes out in order to maximize your profit potential. That's because once earnings are released, IV will fall dramatically, which will greatly reduce your opportunity to profit on the trade. The stocks (with Weekly Options) below are announcing earnings in next few weeks. Our proprietary volatility algorithm suggests these stocks are likely to experience high volatility as earnings day approaches. Symbol Company Earning Date Predicted Volatility * MDB 12/09 11% ORCL 12/09 5% AVXL 12/09 6% SFIX 12/10 17% GME 12/10 7% PLAY 12/10 5% ASO 12/10 7% CIEN 12/12 9% MOMO 12/13 8% FCEL 12/17 8% MU 12/18 6% BB 12/19 6% NKE 12/19 5% WBA 01/02 5% TLRY 01/14 10% URI 01/22 6% EDU 01/22 6% NOW 01/22 5% STX 01/22 5% TSLA 01/22 5% Click Here to View Your Full Report Before Market Open After Market Close *Predicted Volatility % based on our Proprietary Volatility Predication Model. We are expecting that stock price will likely to reach % in either direction by the end of next trading session after Earnings are released and not necessarily the closing volatility %. ֎ AI's NEXT Magnificent Seven (ad) The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years. But the Man Who Called Nvidia at $1.10 Says "AI's Next Magnificent Seven Could Do It Even Faster." 🚀 See His Breakdown of the Seven Stocks You Should Own Here. ✅ China's Quantum Threat: Are You Prepared? ✅ (ad)* The NSA has issued a chilling warning about China getting its hands on a "quantum computer" … If this doomsday scenario happens, all secrets will be exposed and nothing connected to the internet will be safe from the Communists. But one little-known tech company has developed a solution to stop them in their tracks … and there's still time for investors to get on board. 👉 Don't miss out on this critical opportunity. Read the free report now! At StockEarnings, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader. To your trading success, Hiral Ghelani Founder & CEO StockEarnings, Inc 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA W: 877.6.STOCKS (Mon to Sat | 9am to 5pm EST | Feel Free to Call Us) StockEarnings SMS is Here!  Join SMS Text and never miss any stock trade alerts or special offers from StockEarnings and our advertising partners ever again... Click right here to join StockEarnings SMS List (ad)* This message is a PAID ADVERTISEMENT for Scope Technologies Corp. (OTCQB: SCPCF/CSE: SCPE) from Creative Direct Marketing Group, Inc. StockEarnings, Inc. has received a fixed fee of $30,000 from Creative Direct Marketing Group, Inc. for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between December 2, 2024 and December 12, 2024. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either Scope Technologies Corp. (OTCQB: SCPCF/CSE: SCPE) or Creative Direct Marketing Group, Inc. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Scope Technologies Corp. (OTCQB: SCPCF/CSE: SCPE) on The Investment Journal website for additional information about the relationship between Creative Direct Marketing Group, Inc. and Scope Technologies Corp. (OTCQB: SCPCF/CSE: SCPE). (ad)** This message is a PAID ADVERTISEMENT for BirchBioMed Inc. (Reg A+) from i2i Marketing Group, LLC. StockEarnings, Inc. has received a fixed fee of $4,000 from i2i Marketing Group, LLC. for multiple Email sends and Newsletter Sponsorships between December 02, 2024 and December 12, 2024. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either BirchBioMed Inc. (Reg A+) or i2i Marketing Group, LLC. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding BirchBioMed Inc. (Reg A+) on BirchBioMed website for additional information about the relationship between i2i Marketing Group, LLC. and BirchBioMed Inc. (Reg A+). StockEarnings, Inc (SE) is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities. This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised. All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers. Unsubscribe Today's Bonus Content: Can just One Ticker lead to a Successful Retirement? (By clicking the link above, you'll be opted into Behind the Markets free newsletter. You may unsubscribe at any time. (privacy policy))